| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 557.23B | 658.94B | 547.78B | 542.70B | 608.06B | 495.83B |
| Gross Profit | 73.13B | 85.35B | 71.67B | 70.45B | 78.51B | 60.55B |
| EBITDA | 29.18B | 33.13B | 28.96B | 33.27B | 37.26B | 25.51B |
| Net Income | 17.62B | 31.10B | 17.08B | 20.34B | 23.07B | 15.40B |
Balance Sheet | ||||||
| Total Assets | 299.25B | 403.69B | 305.67B | 286.79B | 286.22B | 272.14B |
| Cash, Cash Equivalents and Short-Term Investments | 75.46B | 89.85B | 80.34B | 66.77B | 52.80B | 41.31B |
| Total Debt | 24.86B | 80.37B | 33.49B | 34.27B | 41.94B | 51.17B |
| Total Liabilities | 132.79B | 220.18B | 139.29B | 135.56B | 156.48B | 166.34B |
| Stockholders Equity | 166.35B | 183.50B | 166.22B | 150.84B | 129.61B | 105.68B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -6.26B | 19.80B | 23.97B | 26.88B | -4.83B |
| Operating Cash Flow | 0.00 | -2.47B | 25.05B | 29.39B | 30.57B | -1.55B |
| Investing Cash Flow | 0.00 | -3.47B | -9.85B | -2.75B | -4.80B | -6.77B |
| Financing Cash Flow | 0.00 | 20.33B | -7.46B | -17.19B | -15.55B | 1.16B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥99.22B | 14.91 | ― | 2.72% | -3.00% | -13.90% | |
74 Outperform | ¥202.85B | 5.88 | 17.09% | 2.94% | 20.29% | 94.13% | |
72 Outperform | ¥55.32B | 14.67 | ― | 4.12% | 6.27% | 31.76% | |
67 Neutral | ¥21.59B | 15.35 | ― | 3.83% | 21.81% | -49.75% | |
64 Neutral | ¥40.20B | 8.77 | ― | 5.16% | 1.23% | -22.74% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
59 Neutral | ¥47.44B | 32.39 | 1.55% | 1.34% | -14.56% | 181.24% |